News
For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.
Phase II Trial of ASM8 in Asthma Commences
Pharmaxis today announced it had enrolled the first subjects into a Phase II clinical trial evaluating the new asthma drug, ASM8, in patients with allergic asthma.
Read full media release - pdf
Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results
Pharmaxis today announced significant results of pooled data from its two large scale six month Phase III trials of Bronchitol (inhaled mannitol) in people with cystic fibrosis.
Read full media release - pdf
Pharmaxis Chief Executive Officer Resumes Office
The Chairman of the Pharmaxis Ltd Board, Mr Denis Hanley is pleased to advise that Dr Alan Robertson has today resumed the role of Chief Executive Officer after a period of medical leave.
Read full media release - pdf